-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
LAVA Medtech Acquisition Corp. Announces the Separate Trading of its shares of Class A Common Stock and Warrants, Commencing December 17, 2021
LAVA Medtech Acquisition Corp. Announces the Separate Trading of its shares of Class A Common Stock and Warrants, Commencing December 17, 2021
Waltham, MA, Dec. 16, 2021 (GLOBE NEWSWIRE) -- LAVA Medtech Acquisition Corp. (the "Company") (NASDAQ: LVACU) announced today that, commencing December 17, 2021, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's shares of Class A common stock and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The shares of Class A common stock and the warrants that are separated will trade on the Nasdaq Capital Market ("Nasdaq") under the ticker symbols "LVAC" and "LVACW," respectively. Those units not separated will continue to trade on Nasdaq under the symbol "LVACU." Holders of the units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, to separate the units into shares of Class A common stock and warrants.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About LAVA Medtech Acquisition Corp.
The Company is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
The Company is led by Chairman Richard "Dick" Emmitt; Chief Executive Officer Anthony Natale, M.D.; President Gerry Brunk; Executive Vice President Daniel Hetu, M.D.; and Chief Financial Officer Vasco Larcina. In addition to Dr. Natale and Messrs. Brunk and Emmitt, the Company's Board of Directors includes Peter van der Velden and Fritz LaPorte.
Cautionary Note Concerning Forward-Looking Statements
This press release contains statements that constitute "forward-looking statements." Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and final prospectus for the initial public offering filed with the SEC. Copies are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Contact
Anthony Natale
Chief Executive Officer
Tel: (617) 600-4054
Email: info@lavamedtechacquisition.com
Website:
Waltham, MA, Dec. 16, 2021 (GLOBE NEWSWIRE) -- LAVA Medtech Acquisition Corp. (the "Company") (NASDAQ: LVACU) announced today that, commencing December 17, 2021, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's shares of Class A common stock and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The shares of Class A common stock and the warrants that are separated will trade on the Nasdaq Capital Market ("Nasdaq") under the ticker symbols "LVAC" and "LVACW," respectively. Those units not separated will continue to trade on Nasdaq under the symbol "LVACU." Holders of the units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, to separate the units into shares of Class A common stock and warrants.
马萨诸塞州沃尔瑟姆,2021年12月16日(环球通讯社)熔岩医疗技术收购公司(The公司纳斯达克(股票代码:LVACU)今天宣布,自2021年12月17日起,公司首次公开募股(IPO)中出售的单位的持有人可以选择分开交易公司A类普通股和单位内的权证。单位分离时不会发行零碎的权证,只会发行完整的权证。A类普通股的股票和分离后的权证将在纳斯达克资本市场交易(完)纳斯达克)股票代码分别为“LVAC”和“LVACW”。那些未分离的单位将继续以“LVACU”的代码在纳斯达克上交易。这些单位的持有者需要让他们的经纪人联系大陆股票转让信托公司,该公司的转让代理,将这些单位分离成A类普通股和认股权证。
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
本新闻稿不应构成出售要约或征求购买要约,也不应在任何州或司法管辖区出售这些证券。在根据任何这样的州或司法管辖区的证券法进行注册或获得资格之前,都是非法的。
About LAVA Medtech Acquisition Corp.
关于熔岩医疗技术收购公司。
The Company is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
本公司是一家空白支票公司,其目的是与一家或多家企业进行合并、股本交换、资产收购、股票购买、重组或类似的业务合并。
The Company is led by Chairman Richard "Dick" Emmitt; Chief Executive Officer Anthony Natale, M.D.; President Gerry Brunk; Executive Vice President Daniel Hetu, M.D.; and Chief Financial Officer Vasco Larcina. In addition to Dr. Natale and Messrs. Brunk and Emmitt, the Company's Board of Directors includes Peter van der Velden and Fritz LaPorte.
该公司由董事长理查德·迪克·埃米特、首席执行官安东尼·纳塔尔医学博士、总裁格里·布伦克、执行副总裁总裁、医学博士Daniel和首席财务官瓦斯科·拉西纳领导。除了纳塔莱博士、布伦克先生和埃米特先生之外,公司董事会还包括彼得·范德韦尔登和弗里茨·拉波特。
Cautionary Note Concerning Forward-Looking Statements
警示注意事项:前瞻性陈述
This press release contains statements that constitute "forward-looking statements." Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and final prospectus for the initial public offering filed with the SEC. Copies are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
本新闻稿包含构成“前瞻性陈述”的陈述。前瞻性陈述受许多条件的制约,其中许多条件不是公司所能控制的,包括公司向美国证券交易委员会提交的首次公开募股注册说明书和最终招股说明书中的风险因素部分。可在美国证券交易委员会的网站www.sec.gov上获得副本。公司没有义务向这些统计员提供最新情况除非法律另有要求,否则不得在本新闻稿发布之日后对其进行修订或更改。
Contact
联系方式
Anthony Natale
Chief Executive Officer
Tel: (617) 600-4054
Email: info@lavamedtechacquisition.com
Website:
安东尼·纳塔莱
首席执行官
电话:(617)600-4054
电子邮件:info@lavamedtechquisition.com
网址:中国
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧